Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
Status:
Completed
Trial end date:
2023-01-14
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the safety, tolerability and
pharmacokinetic profiles of SC1011 in healthy conditions. The main questions it aims to
answer are: Safety and tolerability profiles in healthy subjects and pharmacokinetic profiles
in healthy subjects. Participants will complete the study including screening period, dosing
period, and observation period. Investigators will compare the inhibitory activity of SC1011
tablets with pirfenidone capsules against the same biomarkers(e.g. blood TNFα) to see if they
are different between the two drugs.